cinv

Azasetron hydrochloride (Y-25130 HCl) is a 5-HT3 receptor antagonist which is used as an anti-emetic.

Tunicamycin VIII is a useful organic compound for research related to life sciences. The catalog number is T124297 and the CAS number is 73942-07-1.

Tunicamycin VII is a useful organic compound for research related to life sciences. The catalog number is T124449 and the CAS number is 66081-36-5.

5-HT2A/5-HT2C inverse agonist 1 serves as a dual and potent inverse agonist for the 5-HT2A and 5-HT2C receptors, with hERG inhibition properties that mitigate cardiovascular risks. Demonstrating significant antipsychotic efficacy in the MK-801-induced mouse model, this compound holds potential for psychosis research.

Bekanamycin sulfate is an agent of bioactive chemicals.

Albacarcin V is a biochemical.

Leucomycin (Turimycin) is a macrolide antibiotic.

Corynecin V is a chloramphenicol-like bacterial metabolite originally isolated from Corynebacterium.

Tunicamycin 15:1 is a mixture of tunicamycin structural isomers that contains a 15-carbon N-acyl chain with variable branching patterns.References Tunicamycin 15:1 is a mixture of tunicamycin structural isomers that contains a 15-carbon N-acyl chain with variable branching patterns. References

Actinomycin X2 (Actinomycin V) is a compound synthesized by various species of Streptomyces. It displays potent inhibition against methicillin-resistant Staphylococcus aureus (MRSA), with a minimum inhibitory concentration (MIC) of 0.25 μg/mL. Actinomycin X2 possesses potential applications in the treatment of both cancer and bacterial infections.

Leucomycin V is a macrolide antibiotic. Leucomycin A9 exhibits strong activity against Gram-positive bacteria and also affects spirochetes, rickettsiae, and chlamydiae.

Monamycin V is an ester peptide antibiotic that exhibits activity against Gram-positive bacteria.

Nebramycin V (Nebramine factor 5′) is an aminoglycoside antibiotic with broad-spectrum activity against Gram-positive bacteria, Gram-negative bacteria, and mycobacteria.

Mycinamicin VII is a macrolide antibiotic known for its antibacterial activity against Gram-positive bacteria.

Cucurbitacin V is a natural product for research related to life sciences. The catalog number is TN5990 and the CAS number is 152340-37-9.

Gilvocarcin V, a metabolite from Actinomycete DO-38, exhibits potent antibacterial, antifungal, and antiviral activity.

Maridomycin V is a macrolide antibiotic. It is effective against both Gram-positive bacteria and mycoplasmas, and provides protective effects in mice with Gram-positive bacterial infections.

Maridomycin VI is a macrolide antibiotic. It exhibits activity against both Gram-positive bacteria and mycoplasma. Maridomycin VI also provides protective effects in mice infected with Gram-positive bacteria.

Defucogilvocarcin V is an antibiotic with activity against Gram-positive bacteria.

(R,R)-Palonosetron Hydrochloride, the active enantiomer of Palonosetron, is a selective 5-HT3 receptor antagonist used primarily for the prevention of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV).

Casopitant (GW679769) is an orally active neurokinin-1 (NK1) receptor antagonist, researched for its potential use in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV).

Palonosetron, a 5-HT3 antagonist with Ki of 0.17 nM, is used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).

Rolapitant (SCH619734) Hydrochloride is the hydrochloride salt form of rolapitant, an orally bioavailable, centrally-acting, selective, neurokinin 1 receptor (NK1-receptor) antagonist with potential antiemetic activity. Upon oral administration, rolapitant competitively binds to and blocks the activity of the NK1-receptor in the central nervous system, thereby inhibiting the binding of the endogenous ligand, substance P (SP). This may prevent both SP-induced emesis and chemotherapy-induced nausea and vomiting (CINV). The interaction of SP with the NK1-receptor plays a key role in the induction of nausea and vomiting caused by emetogenic cancer chemotherapy. Compared to other NK1-receptor antagonists, rolapitant has both a more rapid onset of action and a much longer half-life.

Rolapitant, also known as SCH-619734, is an orally bioavailable, centrally-acting, selective, neurokinin 1 receptor (NK1-receptor) antagonist with potential antiemetic activity. Upon oral administration, rolapitant competitively binds to and blocks the activity of the NK1-receptor in the central nervous system, thereby inhibiting the binding of the endogenous ligand, substance P (SP). This may prevent both SP-induced emesis and chemotherapy-induced nausea and vomiting (CINV). The interaction of SP with the NK1-receptor plays a key role in the induction of nausea and vomiting caused by emetogenic cancer chemotherapy.